异动解读 | Enovix盘中大跌15.5%,因第二季度前景疲软及智能手机推迟上市拖累增长

异动解读
May 14

Enovix Corporation (ENVX) 今日盘中股价大跌15.50%,引发了市场关注。

消息面上,该公司发布了疲软的第二季度业绩指引。其预测第二季度营收将在80亿至90亿美元区间,这一指引的中值低于分析师普遍预期的86.9亿美元。同时,其核心智能手机业务板块的增长仍然迟滞,主要受智能手机认证延迟及制造瓶颈影响,导致营收增长将慢于预期。

此外,投行奥本海默因此将Enovix的目标价从24美元下调至21美元,尽管维持了“跑赢大盘”的评级。市场普遍认为,这些因素共同导致了投资者信心受挫,从而引发了股价的显著下跌。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10